Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC). (Q33376623)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC). |
scientific article |
Statements
1 reference
Weekly docetaxel, zoledronic acid and estramustine in hormone-refractory prostate cancer (HRPC). (English)
1 reference
Joseph G Kattan
1 reference
Fady S Farhat
1 reference
Georges Y Chahine
1 reference
Fady L Nasr
1 reference
Walid T Moukadem
1 reference
Fariha C Younes
1 reference
Nadine J Yazbeck
1 reference
Marwan G Ghosn
1 reference
Cancer Research Group
1 reference
6 September 2007
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference